Nevro Corp
NVRODelisted- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001444380
Nevro Corp was delisted in 2025; its insiders filed their last Form 4 on Apr 3, 2025; 126 institutions reported holding it in 13F filings for Q1 2025, worth $199.4M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 126
- Q1 2025, −2 vs. previous quarter
- 13F value
- $197.5M
- Reported value at the end of Q1 2025
- Superinvestors holding
- 0
- At the end of Q1 2025
Superinvestors holding NVRO, Q1 2025
No superinvestor reported holding NVRO at the end of Q1 2025.
Latest insider trades
Open-market purchases and sales by Nevro Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2023 (view filing) | Jun 7 | 2 days | McCormick ShawnDirector | PPurchase | +7.50K | $22.88 | +$171.6K | +38.7%26.9K after | |
| May 10, 2022 (view filing) | May 9 | 1 day | Rashid KashifGeneral Counsel | PPurchase | +2.25K | $44.50 | +$100.1K | +4.4%53.5K after | |
| Mar 14, 2022 (view filing) | Mar 11 | 3 days | Rashid KashifGeneral Counsel | PPurchase | +1.50K | $64.04 | +$96.1K | +3.0%51.3K after | |
| Mar 8, 2022 (view filing) | Mar 8 | Same day | Grossman D KeithChairman, President & CEO | PPurchase | +3.20K | $63.59 | +$203.5K | +1.9%169.3K after | |
| Dec 16, 2021 (view filing) | Dec 14 | 2 days | Oboyle Kevin CDirector | PPurchase | +2.40K | $83.78 | +$201.1K | +22.0%13.3K after | 2 lots |
| Nov 22, 2021 (view filing) | Nov 22 | Same day | Weatherman Elizabeth HDirector | PPurchase | +20.0K | $85.33 | +$1.71M | +109.1%38.3K after | 2 lots |
| Nov 15, 2021 (view filing) | Nov 11 | 4 days | Rashid KashifGeneral Counsel | PPurchase | +2.00K | $101.05 | +$202.1K | +6.1%34.5K after | |
| Aug 17, 2021 (view filing) | Aug 13 | 4 days | Grossman D KeithChairman, President & CEO | PPurchase | +7.00K | $105.07 | +$735.5K | +5.9%125.8K after |
Top 10 13F holders, Q1 2025
The largest institutional positions in Nevro Corp at the end of Q1 2025; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Beryl Capital Management LLC | 3,761,191 | $22.0M | 8.21% | +3,761,191 | New |
| BlackRock, Inc. | 2,930,783 | $17.1M | 0.00% | −117,703−3.9% | Reduced |
| Goldman Sachs Group Inc | 2,072,813 | $12.1M | 0.00% | +1,617,676+355.4% | Added |
| Vanguard Group Inc | 2,070,027 | $12.1M | 0.00% | +7,834+0.4% | Added |
| Oddo BHF Asset Management SAS | 1,850,000 | $10.8M | 0.44% | +1,850,000 | New |
| Meteora Capital, LLC | 1,723,715 | $10.1M | 3.56% | +1,723,715 | New |
| Gardner Lewis Asset Management L P | 1,630,291 | $9.52M | 2.29% | +1,630,291 | New |
| Gabelli Funds LLC | 1,322,950 | $7.73M | 0.06% | +1,322,950 | New |
| D. E. Shaw & Co., Inc. | 1,251,830 | $7.31M | 0.01% | −551,702−30.6% | Reduced |
| Renaissance Technologies LLC | 1,209,409 | $7.06M | 0.01% | +909,100+302.7% | Added |